AP5346
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AP5346, covering 2014-01-10 to 2014-01-10. Get the full timeline:
Most recent: Clinical Trial Update: AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer [NA]